Posted by Michael Wonder on 15 Jun 2021
Uptake of medicines for type 2 diabetes mellitus
15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for people with high risk type 2 diabetes mellitus who meet certain criteria.
The total number of people who have a Special Authority approved as at 6 June 2021 = 21,989.
